# EDGAR Filing Document

**Accession Number:** 0001064046
**File Stem:** 0000940400-26-023116
**Filing Date:** 2026-6
**Character Count:** 30627
**Document Hash:** 3539696ddbcfce12deb29eea47c9698d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000940400-26-023116.hdr.sgml**: 20260601

**ACCESSION NUMBER**: 0000940400-26-023116

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260601

**DATE AS OF CHANGE**: 20260601

**PERIOD START**: 20261231

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** RYDEX VARIABLE TRUST
- **CENTRAL INDEX KEY:** 0001064046

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-08821
- **FILM NUMBER:** 261049112

**BUSINESS ADDRESS:**
- **STREET 1:** 702 KING FARM BOULEVARD
- **STREET 2:** SUITE 200
- **CITY:** ROCKVILLE
- **STATE:** MD
- **ZIP:** 20850
- **BUSINESS PHONE:** 301-296-5100

**MAIL ADDRESS:**
- **STREET 1:** 702 KING FARM BOULEVARD
- **STREET 2:** SUITE 200
- **CITY:** ROCKVILLE
- **STATE:** MD
- **ZIP:** 20850

## Series and Classes Contracts Data

### Biotechnology Fund (Series ID: S000003711)

| Class ID   | Class Name       | Ticker Symbol   |
|:---|:---|:---|
| C000010380 | Variable Annuity |  |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Rydex Variable Trust

- **b. Investment Company Act file number:** 811-08821

- **c. CIK number of Registrant:** 0001064046

- **d. LEI of Registrant:** 549300LJH0YR8RY3N305

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 702 KING FARM BOULEVARD

  - **City:** ROCKVILLE

  - **State:** MD

  - **Foreign country:** US

  - **Zip / Postal Code:** 20850

  - **Telephone number:** 301-296-5100

**Item A.2. Information about the Series.**

- **a. Name of Series:** Biotechnology Fund

- **b. EDGAR series identifier (if any):** S000003711

- **c. LEI of Series:** 549300XTVUV4IZ56ON16

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-12-31

- **b. Date as of which information is reported:** 2026-03-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $10708407.77

**Total Liabilities:** $39294.74

**Net Assets:** $10669113.03

**Cash Not Reported:** $8.18

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000010380 | 2.08%                | 2.20%                | -2.49%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $1739.84                 | $264652.97                                 |
| Month 2  | $32294.18                | $224914.75                                 |
| Month 3  | $706930.62               | $-1004397.13                               |

### Schedule of Portfolio Investments

| Name                                               | Title                                                        | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Ultragenyx Pharmaceuticals Inc                     | Ultragenyx Pharmaceuticals Inc COM                           | CUSIP: 90400D108<br>LEI: 529900EV44GVDN1DCX77 | Long             | EC               | CORP              | US        |      2714 | NS      | $56858.30     | 0.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Argenx SE                                          | Argenx SE SPONSORED ADR                                      | CUSIP: 04016X101<br>LEI: 7245009C5FZE6G9ODQ71 | Long             | EC               | CORP              | NL        |       236 | NS      | $172339.00    | 1.62%             |  |  |  | No            |                  1 | On Loan: No      |
| PTC Therapeutics, Inc.                             | PTC Therapeutics, Inc. COM                                   | CUSIP: 69366J200<br>LEI: 549300UJLWOIWFDGB318 | Long             | EC               | CORP              | US        |      1509 | NS      | $102808.17    | 0.96%             |  |  |  | No            |                  1 | On Loan: No      |
| Axsome Therapeutics Inc.                           | Axsome Therapeutics Inc. COM                                 | CUSIP: 05464T104<br>LEI: 549300EXGR0XLRJEIB95 | Long             | EC               | CORP              | US        |       651 | NS      | $110032.02    | 1.03%             |  |  |  | No            |                  1 | On Loan: No      |
| LEGEND BIOTECH CORP                                | Legend Biotech Corporation SPONSORED ADS                     | CUSIP: 52490G102<br>LEI: 254900EIUFZTW136H859 | Long             | EC               | CORP              | KY        |      2794 | NS      | $50543.46     | 0.47%             |  |  |  | No            |                  1 | On Loan: No      |
| SANOFI SA - CVR                                    | SANOFI SA - CVR                                              | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       940 | NS      | $0.09         | 0.00%             |  |  |  | No            |                  3 | On Loan: No      |
| SUMMIT THERAPEUTICS INC                            | Summit Therapeutics Inc. COM                                 | CUSIP: 86627T108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3923 | NS      | $74380.08     | 0.70%             |  |  |  | No            |                  1 | On Loan: No      |
| Krystal Biotech Inc                                | Krystal Biotech Inc COM                                      | CUSIP: 501147102<br>LEI: 549300YONUY68210OE41 | Long             | EC               | CORP              | US        |       197 | NS      | $50889.04     | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Regeneron Pharmaceuticals, Inc.                    | Regeneron Pharmaceuticals, Inc. COM                          | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |       496 | NS      | $383229.44    | 3.59%             |  |  |  | No            |                  1 | On Loan: No      |
| CRISPR Therapeutics AG                             | CRISPR Therapeutics AG COM CHF0.03                           | CUSIP: 000000000<br>LEI: 506700O6IRRIQLT3W370 | Long             | EC               | CORP              | CH        |      2555 | NS      | $121541.35    | 1.14%             |  |  |  | No            |                  1 | On Loan: No      |
| BEONE MEDICINES LTD                                | BeOne Medicines Ltd. SPONSORED ADS                           | CUSIP: 07725L102<br>LEI: 549300JFUK6FRD5MH739 | Long             | EC               | CORP              | CH        |       829 | NS      | $246188.13    | 2.31%             |  |  |  | No            |                  1 | On Loan: No      |
| Sarepta Therapeutics Inc                           | Sarepta Therapeutics Inc COM                                 | CUSIP: 803607100<br>LEI: 549300IKDPIED8J8IG21 | Long             | EC               | CORP              | US        |      3207 | NS      | $69784.32     | 0.65%             |  |  |  | No            |                  1 | On Loan: No      |
| Revolution Medicines Inc                           | Revolution Medicines Inc COM                                 | CUSIP: 76155X100<br>LEI: 549300JU3X0LBCQ65892 | Long             | EC               | CORP              | US        |      1871 | NS      | $181954.75    | 1.71%             |  |  |  | No            |                  1 | On Loan: No      |
| Kymera Therapeutics Inc                            | Kymera Therapeutics Inc COM                                  | CUSIP: 501575104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       929 | NS      | $77376.41     | 0.73%             |  |  |  | No            |                  1 | On Loan: No      |
| NATERA INC                                         | Natera Inc. COM                                              | CUSIP: 632307104<br>LEI: 529900CQ3OZ0A0VYVU59 | Long             | EC               | CORP              | US        |      1128 | NS      | $225588.72    | 2.11%             |  |  |  | No            |                  1 | On Loan: No      |
| Twist Bioscience Corporation                       | Twist Bioscience Corporation COM                             | CUSIP: 90184D100<br>LEI: 549300T23BL59LCOH584 | Long             | EC               | CORP              | US        |      1599 | NS      | $75984.48     | 0.71%             |  |  |  | No            |                  1 | On Loan: No      |
| MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED | MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED TRI PARTY | CUSIP: 000000000<br>LEI: 8NAV47T0Y26Q87Y0QP81 | Long             | RA               | CORP              | US        |     24466 | PA      | $24465.89     | 0.23%             |  |  |  | No            |                  2 | On Loan: No      |
| BioNTech SE                                        | BioNTech SE SPONSORED ADS                                    | CUSIP: 09075V102<br>LEI: 894500UZJ5LG1F8J1U58 | Long             | EC               | CORP              | DE        |      1288 | NS      | $114477.44    | 1.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Alkermes PLC                                       | Alkermes PLC COM USD0.01                                     | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | IE        |      4470 | NS      | $158059.20    | 1.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Protagonist Therapeutics Inc                       | Protagonist Therapeutics Inc COM                             | CUSIP: 74366E102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       893 | NS      | $94122.20     | 0.88%             |  |  |  | No            |                  1 | On Loan: No      |
| Vaxcyte Inc                                        | Vaxcyte Inc COM                                              | CUSIP: 92243G108<br>LEI: 254900M7NMHTGASX8D95 | Long             | EC               | CORP              | US        |      2103 | NS      | $122205.33    | 1.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Roivant Sciences Ltd                               | Roivant Sciences Ltd SHS                                     | CUSIP: 000000000<br>LEI: 549300DL466NY5J6U724 | Long             | EC               | CORP              | BM        |      5450 | NS      | $150965.00    | 1.41%             |  |  |  | No            |                  1 | On Loan: No      |
| Biomarin Pharmaceutical Inc.                       | Biomarin Pharmaceutical Inc. COM                             | CUSIP: 09061G101<br>LEI: NSLL8ITTRR0J5HEMR848 | Long             | EC               | CORP              | US        |      2371 | NS      | $133937.79    | 1.26%             |  |  |  | No            |                  1 | On Loan: No      |
| Exelixis, Inc.                                     | Exelixis, Inc. COM                                           | CUSIP: 30161Q104<br>LEI: 254900PJQB59O2O95R37 | Long             | EC               | CORP              | US        |      3237 | NS      | $138834.93    | 1.30%             |  |  |  | No            |                  1 | On Loan: No      |
| Royalty Pharma PLC                                 | Royalty Pharma PLC COM USD0.0001 CLASS A                     | CUSIP: 000000000<br>LEI: 549300FGFN7VOK8BZR03 | Long             | EC               | CORP              | GB        |      4443 | NS      | $213130.71    | 2.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Amgen Inc.                                         | Amgen Inc. COM                                               | CUSIP: 031162100<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | EC               | CORP              | US        |      1602 | NS      | $563663.70    | 5.28%             |  |  |  | No            |                  1 | On Loan: No      |
| Ionis Pharmaceuticals, Inc.                        | Ionis Pharmaceuticals, Inc. COM                              | CUSIP: 462222100<br>LEI: 549300SI4ZGLG0BLUZ92 | Long             | EC               | CORP              | US        |      1983 | NS      | $148903.47    | 1.40%             |  |  |  | No            |                  1 | On Loan: No      |
| Bridgebio Pharma Inc                               | Bridgebio Pharma Inc COM                                     | CUSIP: 10806X102<br>LEI: 54930028YG89VTY2J114 | Long             | EC               | CORP              | US        |      2134 | NS      | $158470.84    | 1.49%             |  |  |  | No            |                  1 | On Loan: No      |
| Adma Biologics Inc                                 | Adma Biologics Inc COM                                       | CUSIP: 000899104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      5232 | NS      | $47140.32     | 0.44%             |  |  |  | No            |                  1 | On Loan: No      |
| AstraZeneca PLC                                    | AstraZeneca PLC ORD USD0.25                                  | CUSIP: 000000000<br>LEI: PY6ZZQWO2IZFZC3IOL08 | Long             | EC               | CORP              | GB        |       875 | NS      | $172567.50    | 1.62%             |  |  |  | No            |                  1 | On Loan: No      |
| APOGEE THERAPEUTICS INC                            | Apogee Therapeutics Inc. COM                                 | CUSIP: 03770N101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       962 | NS      | $80971.54     | 0.76%             |  |  |  | No            |                  1 | On Loan: No      |
| Gilead Sciences Inc.                               | Gilead Sciences Inc. COM                                     | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |      3830 | NS      | $533787.10    | 5.00%             |  |  |  | No            |                  1 | On Loan: No      |
| COGENT BIOSCIENCES INC                             | Cogent Biosciences Inc. COM                                  | CUSIP: 19240Q201<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      2770 | NS      | $106617.30    | 1.00%             |  |  |  | No            |                  1 | On Loan: No      |
| GRAIL Inc                                          | GRAIL Inc COM                                                | CUSIP: 384747101<br>LEI: 2549009XSNESW3VE8024 | Long             | EC               | CORP              | US        |      1023 | NS      | $52868.64     | 0.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Celcuity Inc.                                      | Celcuity Inc. COM                                            | CUSIP: 15102K100<br>LEI: 25490070W7UU7W2SEY87 | Long             | EC               | CORP              | US        |       611 | NS      | $69739.54     | 0.65%             |  |  |  | No            |                  1 | On Loan: No      |
| J.P. MORGAN SECURITIES LLC                         | J.P. MORGAN SECURITIES LLC TRI PARTY                         | CUSIP: 000000000<br>LEI: ZBUT11V806EZRVTWT807 | Long             | RA               | CORP              | US        |     26922 | PA      | $26921.76     | 0.25%             |  |  |  | No            |                  2 | On Loan: No      |
| Madrigal Pharmaceuticals Inc                       | Madrigal Pharmaceuticals Inc COM                             | CUSIP: 558868105<br>LEI: 549300CHIMT2EUSNJB60 | Long             | EC               | CORP              | US        |       186 | NS      | $97365.42     | 0.91%             |  |  |  | No            |                  1 | On Loan: No      |
| Travere Therapeutics Inc                           | Travere Therapeutics Inc COM                                 | CUSIP: 89422G107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      2412 | NS      | $71660.52     | 0.67%             |  |  |  | No            |                  1 | On Loan: No      |
| Amicus Therapeutics Inc.                           | Amicus Therapeutics Inc. COM                                 | CUSIP: 03152W109<br>LEI: 549300MRD1SMUTNBPQ53 | Long             | EC               | CORP              | US        |      6081 | NS      | $87931.26     | 0.82%             |  |  |  | No            |                  1 | On Loan: No      |
| LIQUIDIA CORP                                      | Liquidia Corporation COM NEW                                 | CUSIP: 53635D202<br>LEI: 549300O826O5VQJTG707 | Long             | EC               | CORP              | US        |      1765 | NS      | $66611.10     | 0.62%             |  |  |  | No            |                  1 | On Loan: No      |
| Insmed Inc                                         | Insmed Inc COM PAR $.01                                      | CUSIP: 457669307<br>LEI: 529900Q55QAG41CCAC11 | Long             | EC               | CORP              | US        |      1616 | NS      | $264248.32    | 2.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Arrowhead Pharmaceuticals Inc                      | Arrowhead Pharmaceuticals Inc COM                            | CUSIP: 04280A100<br>LEI: 549300O3CSB8T7OZ3D66 | Long             | EC               | CORP              | US        |      2102 | NS      | $131795.40    | 1.24%             |  |  |  | No            |                  1 | On Loan: No      |
| Vertex Pharmaceuticals Incorporated                | Vertex Pharmaceuticals Incorporated COM                      | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |       966 | NS      | $431357.64    | 4.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Incyte Corporation.                                | Incyte Corporation. COM                                      | CUSIP: 45337C102<br>LEI: 549300Z4WN6JVZ3T4680 | Long             | EC               | CORP              | US        |      1779 | NS      | $167439.48    | 1.57%             |  |  |  | No            |                  1 | On Loan: No      |
| Soleno Therapeutics Inc                            | Soleno Therapeutics Inc COM                                  | CUSIP: 834203309<br>LEI: 5493003LCY77N7FXK844 | Long             | EC               | CORP              | US        |      1567 | NS      | $52463.16     | 0.49%             |  |  |  | No            |                  1 | On Loan: No      |
| Rhythm Pharmaceuticals Inc                         | Rhythm Pharmaceuticals Inc COM                               | CUSIP: 76243J105<br>LEI: 529900JPNWXQ8DPLA551 | Long             | EC               | CORP              | US        |       969 | NS      | $84273.93     | 0.79%             |  |  |  | No            |                  1 | On Loan: No      |
| Viatris Inc                                        | Viatris Inc COM                                              | CUSIP: 92556V106<br>LEI: 254900ZZTSW7NL773X71 | Long             | EC               | CORP              | US        |     11963 | NS      | $161620.13    | 1.51%             |  |  |  | No            |                  1 | On Loan: No      |
| Mirum Pharmaceuticals Inc.                         | Mirum Pharmaceuticals Inc. COM                               | CUSIP: 604749101<br>LEI: 254900YZKR40F7F27K81 | Long             | EC               | CORP              | US        |      1043 | NS      | $96352.34     | 0.90%             |  |  |  | No            |                  1 | On Loan: No      |
| Praxis Precision Medicines Inc                     | Praxis Precision Medicines Inc COM NEW                       | CUSIP: 74006W207<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       167 | NS      | $53805.73     | 0.50%             |  |  |  | No            |                  1 | On Loan: No      |
| ARCUTIS BIOTHERAPEUTICS INC                        | Arcutis Biotherapeutics Inc. COM                             | CUSIP: 03969K108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      2943 | NS      | $69337.08     | 0.65%             |  |  |  | No            |                  1 | On Loan: No      |
| Moderna Inc                                        | Moderna Inc COM                                              | CUSIP: 60770K107<br>LEI: 549300EI6OKH5K5Q2G38 | Long             | EC               | CORP              | US        |      3493 | NS      | $177444.40    | 1.66%             |  |  |  | No            |                  1 | On Loan: No      |
| Halozyme Therapeutics Inc                          | Halozyme Therapeutics Inc COM                                | CUSIP: 40637H109<br>LEI: 529900242I3SV9AGM753 | Long             | EC               | CORP              | US        |      1811 | NS      | $117044.93    | 1.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Neurocrine Biosciences Inc                         | Neurocrine Biosciences Inc COM                               | CUSIP: 64125C109<br>LEI: 549300FECER0XBN49756 | Long             | EC               | CORP              | US        |      1158 | NS      | $152554.92    | 1.43%             |  |  |  | No            |                  1 | On Loan: No      |
| Alnylam Pharmaceuticals Inc.                       | Alnylam Pharmaceuticals Inc. COM                             | CUSIP: 02043Q107<br>LEI: 529900S3ZI14OWRJII50 | Long             | EC               | CORP              | US        |       848 | NS      | $280577.76    | 2.63%             |  |  |  | No            |                  1 | On Loan: No      |
| Acadia Pharmaceuticals Inc                         | Acadia Pharmaceuticals Inc COM                               | CUSIP: 004225108<br>LEI: 529900O3044NO0PEA039 | Long             | EC               | CORP              | US        |      3242 | NS      | $72166.92     | 0.68%             |  |  |  | No            |                  1 | On Loan: No      |
| Arcellx Inc                                        | Arcellx Inc COMMON STOCK                                     | CUSIP: 03940C100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       928 | NS      | $106552.96    | 1.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Akero Therapeutics Inc                             | Akero Therapeutics Inc                                       | CUSIP: 009CVR044<br>LEI: 549300SI3KG74LBE2955 | Long             | EC               | CORP              | US        |      1848 | NS      | $0.18         | 0.00%             |  |  |  | No            |                  3 | On Loan: No      |
| Veracyte Inc                                       | Veracyte Inc COM                                             | CUSIP: 92337F107<br>LEI: 529900ESWZRHXOW27Z37 | Long             | EC               | CORP              | US        |      2127 | NS      | $68510.67     | 0.64%             |  |  |  | No            |                  1 | On Loan: No      |
| Medpace Holdings Inc.                              | Medpace Holdings Inc. COM                                    | CUSIP: 58506Q109<br>LEI: 549300H8TYEUVTW14A54 | Long             | EC               | CORP              | US        |       282 | NS      | $135413.58    | 1.27%             |  |  |  | No            |                  1 | On Loan: No      |
| AbbVie Inc.                                        | AbbVie Inc. COM                                              | CUSIP: 00287Y109<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | EC               | CORP              | US        |      3661 | NS      | $796230.89    | 7.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Jazz Pharmaceuticals PLC                           | Jazz Pharmaceuticals PLC COM USD0.0001                       | CUSIP: 000000000<br>LEI: 635400GAUMJCLEZRRV50 | Long             | EC               | CORP              | IE        |       833 | NS      | $157478.65    | 1.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Guardant Health Inc                                | Guardant Health Inc COM                                      | CUSIP: 40131M109<br>LEI: 254900M8C3E5VC8BR186 | Long             | EC               | CORP              | US        |      1643 | NS      | $151763.91    | 1.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Recursion Pharmaceuticals Inc                      | Recursion Pharmaceuticals Inc CL A                           | CUSIP: 75629V104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     16655 | NS      | $51130.85     | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| BEAM THERAPEUTICS INC                              | Beam Therapeutics Inc. COM                                   | CUSIP: 07373V105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      2543 | NS      | $60599.69     | 0.57%             |  |  |  | No            |                  1 | On Loan: No      |
| United Therapeutics Corporation                    | United Therapeutics Corporation COM                          | CUSIP: 91307C102<br>LEI: 5299005C4HZL4UWROC14 | Long             | EC               | CORP              | US        |       376 | NS      | $222960.48    | 2.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Apellis Pharmaceuticals Inc                        | Apellis Pharmaceuticals Inc COM                              | CUSIP: 03753U106<br>LEI: 254900HS0ZFRXXSB9D42 | Long             | EC               | CORP              | US        |      3277 | NS      | $131833.71    | 1.24%             |  |  |  | No            |                  1 | On Loan: No      |
| Illumina Inc                                       | Illumina Inc COM                                             | CUSIP: 452327109<br>LEI: SQ95QG8SR5Q56LSNF682 | Long             | EC               | CORP              | US        |      1519 | NS      | $187231.94    | 1.75%             |  |  |  | No            |                  1 | On Loan: No      |
| Cytokinetics Inc                                   | Cytokinetics Inc COM NEW                                     | CUSIP: 23282W605<br>LEI: 549300BE5DY1HW7IHA64 | Long             | EC               | CORP              | US        |      1921 | NS      | $126613.11    | 1.19%             |  |  |  | No            |                  1 | On Loan: No      |
| TG Therapeutics Inc                                | TG Therapeutics Inc COM                                      | CUSIP: 88322Q108<br>LEI: 529900X21UKABN9NJ529 | Long             | EC               | CORP              | US        |      3127 | NS      | $103878.94    | 0.97%             |  |  |  | No            |                  1 | On Loan: No      |
| Scholar Rock Holding Corp.                         | Scholar Rock Holding Corp. COM                               | CUSIP: 80706P103<br>LEI: 549300Z1FLPGL4OWJ459 | Long             | EC               | CORP              | US        |      2063 | NS      | $101417.08    | 0.95%             |  |  |  | No            |                  1 | On Loan: No      |
| Biogen Inc                                         | Biogen Inc COM                                               | CUSIP: 09062X103<br>LEI: W8J5WZB5IY3K0NDQT671 | Long             | EC               | CORP              | US        |      1180 | NS      | $216329.40    | 2.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Intellia Therapeutics Inc                          | Intellia Therapeutics Inc COM                                | CUSIP: 45826J105<br>LEI: 5493002T5BCPE5DZC723 | Long             | EC               | CORP              | US        |      3943 | NS      | $50549.26     | 0.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Viking Therapeutics Inc.                           | Viking Therapeutics Inc. COM                                 | CUSIP: 92686J106<br>LEI: 529900IVC72YPFA25M37 | Long             | EC               | CORP              | US        |      2334 | NS      | $75948.36     | 0.71%             |  |  |  | No            |                  1 | On Loan: No      |
| Ascendis Pharma A/S                                | Ascendis Pharma A/S SPONSORED ADR                            | CUSIP: 04351P101<br>LEI: 549300B66JN3W3J8GH73 | Long             | EC               | CORP              | DK        |       476 | NS      | $108875.48    | 1.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Nuvalent Inc                                       | Nuvalent Inc COM                                             | CUSIP: 670703107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       722 | NS      | $73968.90     | 0.69%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2026-06-01

**Name of Applicant:** Rydex Variable Trust

**Signature:** James Howley

**Name of Signer:** James Howley

**Title:** Chief Financial Officer